Open original FDA record ↗Recall record
- FDA identifier
- Z-1519-2018
- Company in FDA record
- Roche Diagnostics Corporation
- FDA record creation date
- Apr 25, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The previous version of method sheets for the Acetaminophen assay on the COBAS INTEGRA 400 plus/800/800 CTS analyzers and the MODULAR ANALYTICS P module are missing the following statement in the Limitations-interference section: "In very rare cases, gammopathy, in particular type IgM (Waldenstrm s macroglobulinemia), may cause unreliable results."
Source facts
- Action
- On January 2, 2018 an URGENT MEDICAL DEVICE CORRECTION letter was issued to customers with notification to the issue and information regarding the updated method sheets and that they were available for use. The COBAS INTEGRA 400 plus/800/800 CTS was updated from affected method sheet version 3.0 to 4.0. The MODULAR ANALYTICS P was updated from affected method sheet version 4.0 to 5.0 No product return is required. Please contact the Roche Support Network Customer Support Center, 24 hours a day, seven days a week at 1-800-428-2336 if you have questions about the information contained in this UMDC.
- Initiated
- 2018-01-02
- Root cause
- Error in labeling
- Terminated
- 2019-04-25
- Distribution
- Nationwide Distribution
- Recall number
- Z-1519-2018
- Recall status
- Terminated
- CDRH record ID
- 162582
- FDA record created
- 2018-04-25
- Recall event number
- 79526